Tolbert, Lelia
Borden, Sarah
Leskowitz, Jamie
Ramakrishnan, Rajasekhar
Reid, Tirissa
Krikhely, Abraham
Bessler, Marc
Korner, Judith
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (DK072011)
National Center for Advancing Translational Sciences (UL1TR001873)
Article History
Received: 2 November 2025
Revised: 11 December 2025
Accepted: 22 December 2025
First Online: 6 February 2026
Declarations
:
: All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: A.K. served as Consultant for The Network Effects. J.K. has served on the Advisory Boards of Found Health, Gila Therapeutics and Morphic Medical; has stock ownership in Found Health; has served on the Board of Directors of the American Board of Obesity Medicine; has served as Consultant for the Federal Trade Commission, Apotex, Equinox, Canaccord Genuity, Sago, Bristol Meyers Squibb; has received roylaties for UptoDate.